Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2009

Nov 14, 2009

29777_dirs_2009-11-13_c7b6d2b2-d801-4b86-8086-a954717616f8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2009-11-11

Reporting Person: Mason Heather L (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-11-11 Common shares without par value M 1274 $51.91 Acquired 104543 Direct
2009-11-11 Common shares without par value M 878 $53.24 Acquired 105421 Direct
2009-11-11 Common shares without par value S 2152 $53.50 Disposed 103269 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2009-11-11 Option (right to buy) $51.91 M 1274 Disposed 2010-02-10 Common shares (1274) Direct
2009-11-11 Option (right to buy) $53.24 M 878 Disposed 2010-02-10 Common shares (878) Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.